Loading…

Prostate-specific antigen (PSA) velocity: a test of controversial benefit in the era of increased prostate cancer screening

Determining the need for prostate biopsy remains one of the most controversial questions in urology. Over the past 10 years, practice guidelines have changed dramatically, especially among asymptomatic men with low prostate-specific antigen (PSA) and negative digital rectal exam. Thompson et al.

Saved in:
Bibliographic Details
Published in:亚洲男性学杂志:英文版 2011, Vol.13 (4), p.614-615
Main Author: Michael S Borofsky Danil V Makarov
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Determining the need for prostate biopsy remains one of the most controversial questions in urology. Over the past 10 years, practice guidelines have changed dramatically, especially among asymptomatic men with low prostate-specific antigen (PSA) and negative digital rectal exam. Thompson et al.
ISSN:1008-682X
1745-7262